stella
beta
IL-2 Plus Abatacept in FTD — Stella
Recruiting
Back to Frontotemporal Degeneration trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Houston Methodist Research Institute, Houston, Texas
View full record on ClinicalTrials.gov